Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kristin Abate currently holds 23,782 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristin Abate has been a net seller of KPTI stock. They have purchased $0 and sold $5.1K worth of shares.
Kristin Abate's most recent insider trade was on Sep 1, 2026, when they sold 19 shares at $2.02 per share.
Kristin Abate serves as Executive at Karyopharm Therapeutics Inc. (KPTI). They have executed 8 insider transactions totaling $5.1K over their tenure at the company.
Kristin Abate holds the position of Executive at Karyopharm Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Kristin Abate has shown a selling trading pattern, with $0 in total purchases and $5.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kristin Abate was on Oct 1, 2025, when they sold $2.3K worth of KPTI shares. This transaction involved 362 shares at $6.30 per share.
Kristin Abate currently owns 23,782 shares of Karyopharm Therapeutics Inc. (KPTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kristin Abate's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kristin Abate has 8 Form 4 filings on record as an insider at Karyopharm Therapeutics Inc..
Set alerts for Kristin Abate and 40,000+ other insiders.